Catalyst

Slingshot members are tracking this event:

Genmab/Novartis' Arzerra (Ofatumumab) as Maintenance Therapy for Relapsed chronic lymphocytic leukemia PDUFA target date set to January 21, 2016

Source Link:
http://ir.genmab.com/releasedetail.cfm?ReleaseID=932308

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
NVS Community voting in process
OMX: GEN Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jan 19, 2016
Occurred Source:
http://ir.genmab.com/releasedetail.cfm?ReleaseID=950799
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Pdufa, Arzerra, Oftamumab, Relapsed Chronic Lymphocytic Leukemia
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.